文献速递外周动脉疾病

美国外周动脉疾病与慢性阻塞性肺疾病共病死亡率趋势(1999-2023)

Trends in Mortality-Related to Peripheral Artery Disease and Chronic Obstructive Pulmonary Disease Comorbidity in the United States (1999-2023).
PubMed 文献 · Ann Vasc Surg · 2025-10-13

研究基于美国CDC WONDER数据库1999至2023年死亡数据,分析同时列出PAD和COPD的死亡证明。共283,974例死亡,总年龄调整死亡率(AAMR)为5.50。AAMR在2001-2017年显著下降(APC -3.06%),但2017-2021年上升(APC 5.72%)。

要点

  • PAD与COPD共病患者总AAMR为5.50,2001-2017年下降后2017-2021年反弹上升。
  • 男性AAMR高于女性(7.84 vs 4.25),65岁以上人群粗死亡率最高(24.8)。
  • 非都市区死亡率(7.2)高于都市区(5.11),中西部AAMR最高(6.42)。

核心结论

  • 尽管1999-2023年PAD与COPD共病相关总死亡率下降,但近期在老年人、男性、农村人口及特定地区出现上升,凸显持续差异。
  • PAD或COPD单独死亡率持续下降,但共病患者近年死亡率出现逆转,上升幅度不成比例。

研究设计与样本

  • 研究提取美国CDC WONDER数据库1999-2023年死亡数据,使用ICD-10编码(PAD: I70.x和I73.9;COPD: J40-J44)。
  • 从Multiple Cause of Death Public Use Record识别同时列出PAD和COPD的死亡证明,无论作为根本死因或 contributing cause。
  • 计算年龄调整死亡率(AAMR),按年龄组、性别、种族、州、城市化程度和地区分层。
  • 采用Joinpoint回归分析评估趋势、年度百分比变化(APC)和平均年度百分比变化。

主要发现

  • 共283,974例PAD与COPD共病死亡,总AAMR为5.50。
  • AAMR在2001-2017年显著下降(APC: -3.06%, 95%CI: -3.41, -2.72),2017-2021年上升(APC: 5.72%, 95%CI: 1.85, 9.73)。
  • 男性总体AAMR高于女性(7.84 vs. 4.25)。
  • 白人种族特异性AAMR最高(6.13),65岁以上组粗死亡率最高(24.8)。
  • 西弗吉尼亚州AAMR最高(10.51, 95%CI: 10.16-10.86),非都市区死亡率(7.2)高于都市区(5.11),中西部AAMR最高(6.42)。

临床怎么用

  • 临床应关注PAD与COPD共病患者,尤其老年人、男性、农村居民及特定高死亡率地区。
  • 需持续监测共病死亡率趋势,并针对高风险人群实施靶向慢性病干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peripheral artery disease (PAD) and chronic obstructive pulmonary disease (COPD) often coexist, contributing to elevated mortality due to shared etiologic factors such as tobacco use, chronic systemic inflammation, and aging-related vascular degeneration. National trends in the combined burden of PAD and COPD remain under-investigated. This study aims to demonstrate trends and demographic patterns in deaths associated with both COPD and PAD in the United States from 1999 to 2023. METHODS: Mortality data from 1999 to 2023 were extracted from the Centers for Disease Control and Prevention's Wide-ranging Online Data for Epidemiologic Research database using International Classification of Diseases, Tenth Revision codes corresponding to PAD and COPD (I70.x and I73.9 for PAD and J40-J44 for COPD). Data from the Multiple Cause of Death Public Use Record were used to identify death certificates that listed both PAD and COPD simultaneously, whether as the underlying or contributing cause of death. Age-adjusted mortality rates (AAMRs) were calculated, stratified by age group, sex, race, state, urbanization, and region. Joinpoint regression analysis was used to evaluate trends and annual percent changes (APCs) and average annual percent change. RESULTS: A total of 283,974 deaths were reported among individuals with coexisting PAD and COPD, with an overall AAMR of 5.50. AAMRs declined significantly between 2001 and 2017 (APC: -3.06%, 95% confidence interval [CI]: -3.41, -2.72) but rose from 2017 to 2021 (APC: 5.72%, 95% CI: 1.85, 9.73). Males had a higher overall AAMR than females (7.84 vs. 4.25). The White population had the highest race-specific AAMR (6.13), and crude rates were highest in the 65+ age group (24.8). Geographically, West Virginia reported the highest state-level AAMR (10.51) (95% CI: 10.16-10.86). Nonmetropolitan areas had higher mortality rates (7.2) compared to metropolitan areas (5.11). Regionally, the Midwest exhibited the highest AAMR (6.42). CONCLUSION: Although overall mortality related to PAD and COPD declined from 1999 to 2023, recent increases-particularly among older adults, males, the rural population, and specific geographic regions-highlight persistent disparities. While mortality from PAD or COPD alone has continued to decline, recent years have shown a reversal in patients with coexisting PAD and COPD, where mortality is rising disproportionately compared with either disease in isolation. These findings underscore the importance of continued surveillance and targeted chronic disease interventions to reduce mortality in high-risk populations.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Waseem N, Ihtasham A, Tariq W, et al. Trends in Mortality-Related to Peripheral Artery Disease and Chronic Obstructive Pulmonary Disease Comorbidity in the United States (1999-2023). Ann Vasc Surg. 2025. PMID: 41093102. doi:10.1016/j.avsg.2025.09.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。